Good battle during lunch when the heavy bulls are not at their desks. Be careful shorting or you will be caught in a gutter this afternoon
Sentiment: Strong Buy
Roll your profits into GNSZ. Data release tomorrow for liver cancer. This is gonna explode. Data release was moved up from previously announced release. They must have good news to announce at the conference tomorrow.
It has been confirmed there will be a PR in morning with data update. You don't think that will create attention? That's what your saying right? They won't get any attention with just a poster?
Hey Maryland, AMBS has a diagnostic which had great results but is only for clinical testing so far. They will hopefully get CLIA approval to broaden their market. As for AVXL they are much farther along than AMBS for AD therapeutics. AMBS' MANF is very promising a therapuetic but is still in the pre-clinical stages.